Paclitaxel- and Sirolimus-coated Balloons in Peripheral Artery Disease Treatment: Current Perspectives and Concerns
Drug-coated balloons (DCBs) have become an established therapy for the treatment of above-the-knee peripheral artery disease. The paclitaxel DCB has shown clinical benefit in terms of patency and freedom from re-intervention in multiple randomised trials. However, a recent meta-analysis has suggeste...
Guardado en:
Autores principales: | Masayuki Mori, Atsushi Sakamoto, Rika Kawakami, Yu Sato, Hiroyuki Jinnouchi, Kenji Kawai, Anne Cornelissen, Renu Virmani, Aloke V Finn |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Radcliffe Medical Media
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f91c206208b44a8a880d3e366e62a358 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
IN.PACTTM AdmiralTM drug-coated balloons in peripheral artery disease: current perspectives
por: Torii S, et al.
Publicado: (2019) -
A novel paclitaxel coated balloon with increased drug transfer for treatment of complex vascular lesions.
por: Ole Gemeinhardt, et al.
Publicado: (2021) -
A novel paclitaxel coated balloon with increased drug transfer for treatment of complex vascular lesions
por: Ole Gemeinhardt, et al.
Publicado: (2021) -
Treatment of cephalic arch stenosis in dysfunctional arteriovenous fistulas with paclitaxel-coated versus conventional balloon angioplasty
por: Ren Kwang A. Tng, et al.
Publicado: (2021) -
Head-to-head comparison of sirolimus-eluting stents versus paclitaxel-eluting stents in patients undergoing percutaneous coronary intervention: a meta-analysis of 76 studies.
por: Xinlin Zhang, et al.
Publicado: (2014)